skip to primary navigationskip to content
 

GeneAdviser raises £350K to boost uptake of genomic medicine

last modified Jun 02, 2016 08:50 AM
GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.
Formed by a growing team of Cambridge scientists and geneticists, the company provides an independent platform for clinicians to quickly compare and order specialist genetics services, advancing the uptake of genomic medicine into the healthcare market.
The £350,000 seed round is led by Abcam founder and life science investor Jonathan Milner, who joins the board of directors as company chairman. Further funds are contributed by Dr Darrin Disley (Horizon Discovery), Dr Chris Torrance (Phoremost), Simon Thorpe (Delta2020), Martlet and other individual investors.
GeneAdviser fills a great need for accessible genetic testing and will significantly impact the lives of patients with rare disease, cancer and neurological conditions,” says Dr Milner. “It shows real potential to scale quickly and become the market leader in this space. I’m impressed by the way the team has created the platform over the past year and look forward to helping them make their ambitious longer-term plans a reality.”
Clinicians are already using GeneAdviser to order specialist genetic tests from the NHS Regional Genetics Centre at Addenbrooke’s Hospital in Cambridge. This funding will allow GeneAdviser to expand the ordering platform into a broader marketplace, making it easier for clinicians worldwide to select and order genetics services. 
Link to the full story: http://bit.ly/GeneAdviser-funding

RSS Feed Latest news

ideaSpace Vacancy: Operations and Office Manager

May 09, 2019

ideaSpace are looking for an Operations and Office Manager based at ideaSpace South on the Cambridge Biomedical Campus. The closing date for applications is 3 June 2019.

LESSONS FROM A FOUNDER: When It Runs in the Family - Starting a Business with Your Brother

Apr 25, 2019

This month, in recognition of National Siblings Day, here’s the story of ideaSpace City members, Smart Acoustics, a team of two brothers who are taking on the world of ultrasound for the best of reasons.

LESSONS FROM A FOUNDER: Taking Your Technology to Market with Scott White from PragmatIC

Mar 14, 2019

Scott White, ideaSpace alumni and serial entrepreneur is CEO of PragmatIC. PragmatIC produces sheets of flexible integrated circuits (FlexICs), extending the reach of electronics into markets unfeasible for silicon for reasons of form factor and/or cost. Printed electronics is one of the world’s fastest growing technologies, representing enormous potential in interconnected devices. In recognition of British Science Week, we spoke to Scott about the company’s journey from a technology-based concept to the production of commercial products, and asked his advice about taking a new technology to market.

LESSONS FROM A FOUNDER: Basics of Building a Business - IP with Christian Bunke

Feb 28, 2019

With the next B3 event coming up in the next few weeks, we thought we’d take a look back at some previous B3s and learn more about what it takes to build a business. But first – a bit about B3. Our Basics of Building a Business event, or B3, is hosted by a Founder who has successfully scaled their business. They invite the three people who proved vital in helping them along the way to share what they did, how they did it and so much more on what you need to do to go from start up to scale up. Late last year Adam Durant, CEO of Satavia and alumni of ideaSpace, was our guest founder for the evening and invited along Christian Bunke of Basck - an IP Firm focused on working with startups. Here’s what he had to say…

Spotlight on Mursla

Feb 03, 2019

Cancer is one of the most challenging global issues an entrepreneur could choose to tackle. But Pierre Arsène and Victor Serdio are doing just that with their company Mursla. Based at ideaSpace West, Mursla is developing a breakthrough technology for early cancer detection using liquid biopsies, offering a less invasive and more responsive approach to diagnosis, treatment and cure. To mark World Cancer Day on the 4th February, we asked Pierre to explain more about Mursla and the bold ideas and enthusiasm driving this bright company.

View all news